Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Pregabalin
Clonmel Healthcare Ltd
N03AX16
Pregabalin
100mg
Capsule, hard
Oral use
21 or 84 capsules, hard
Product subject to prescription which may not be renewed (A)
Antiepileptics, other antiepileptics
It is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation and for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Authorised
2015-07-31
1 PACKAGE LEAFLET: INFORMATION FOR THE USER BELIGANTE 25 MG CAPSULES, HARD BELIGANTE 50 MG CAPSULES, HARD BELIGANTE 75 MG CAPSULES, HARD BELIGANTE 100 MG CAPSULES, HARD BELIGANTE 150 MG CAPSULES, HARD BELIGANTE 200 MG CAPSULES, HARD BELIGANTE 225 MG CAPSULES, HARD BELIGANTE 300 MG CAPSULES, HARD Pregabalin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Beligante is and what it is used for 2. What you need to know before you take Beligante 3. How to take Beligante 4. Possible side effects 5. How to store Beligante 6. Contents of the pack and other information 1. WHAT BELIGANTE IS AND WHAT IT IS USED FOR Beligante belongs to a group of medicines used to treat epilepsy, neuropathic pain and Generalised Anxiety Disorder (GAD) in adults. PERIPHERAL AND CENTRAL NEUROPATHIC PAIN: Beligante is used to treat long lasting pain caused by damage to the nerves. A variety of diseases can cause peripheral neuropathic pain, such as diabetes or shingles. Pain sensations may be described as hot, burning, throbbing, shooting, stabbing, sharp, cramping, aching, tingling, numbness, pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, s Les hele dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Beligante 100mg Capsules, Hard 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule, hard contains 100 mg of pregabalin. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, hard. The 100 mg capsule is orange, size 3 (16 mm), marked “PGB 100” on the body with black ink. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _Epilepsy_ Beligante is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. _Generalised Anxiety Disorder_ Beligante is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dose range is 150 to 600 mg per day given in either two or three divided doses. _Epilepsy_ Pregabalin treatment can be started with a dose of 150 mg per day given as two or three divided doses. Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after 1 week. The maximum dose of 600 mg per day may be achieved after an additional week. _Generalised Anxiety Disorder_ The dose range is 150 to 600 mg per day given as two or three divided doses. The need for treatment should be reassessed regularly. Pregabalin treatment can be started with a dose of 150 mg per day. Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after 1 week. Following an additional week the dose may be increased to 450 mg per day. The maximum dose of 600 mg per day may be achieved after an additional week. _Discontinuation of pregabalin_ In accordance with current clinical practice, if pregabalin has to be discontinued it is recommended this should be done gradually over a minim Les hele dokumentet